Volume 36, Issue 1 supplement | Drugs & Aging

Search all Drugs & Aging articles

Volume 36, Issue 1 supplement

April 2019

Reassessment of the Safety of Anti-Osteoarthritis Medications

Issue Editor:

Jean Yves Reginster

10 articles in this issue

Announcement

Announcement 09 May 2019 Pages: 1 - 1
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
Jean-Yves Reginster
Olivier Bruyère
Cyrus Cooper
Foreword Open access 09 May 2019 Pages: 3 - 6
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
Philip G. Conaghan
Nigel Arden
René Rizzoli
Review Article Open access 09 May 2019 Pages: 7 - 14
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
Cyrus Cooper
Roland Chapurlat
Jean-Yves Reginster
Review Article Open access 09 May 2019 Pages: 15 - 24
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Elizabeth Curtis
Nicholas Fuggle
Cyrus Cooper
Systematic Review Open access 09 May 2019 Pages: 25 - 44
Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Germain Honvo
Victoria Leclercq
Olivier Bruyère
Systematic Review Open access 09 May 2019 Pages: 45 - 64
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Germain Honvo
Jean-Yves Reginster
Olivier Bruyère
Systematic Review Open access 09 May 2019 Pages: 65 - 99
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Germain Honvo
Jean-Yves Reginster
Olivier Bruyère
Systematic Review Open access 09 May 2019 Pages: 101 - 127
Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
Nicholas Fuggle
Elizabeth Curtis
Cyrus Cooper
Systematic Review Open access 09 May 2019 Pages: 129 - 143
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Germain Honvo
Raveendhara R. Bannuru
Tim McAlindon
Leading Article Open access 09 May 2019 Pages: 145 - 159